Quarterly report · Q2
6856.TEDINET S100P17D
Period2022-01-01 → 2022-06-30
Filed2022-08-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥115.0bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥224.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥101.3bn | 2021-01-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥16.3bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥13.1bn | 2021-01-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥16.8bn | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥32.0bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.0bn | 2021-01-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥16.8bn | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥13.0bn | 2021-01-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥11.2bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21.3bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥8.7bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥11.2bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥8.7bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥398.4bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥371.6bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥349.0bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥173.8bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥167.1bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥224.6bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥204.5bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥191.6bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥140.0bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥135.0bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥139.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥133.9bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥122.0bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥114.2bn | at 2020-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥10.3bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥15.8bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥14.7bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.9bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥6.9bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.0bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.1bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥266.31 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥130.72 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥505.05 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥207.24 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥114.81 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥264.93 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥502.46 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥206.2 | 2021-01-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 56.2% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.8% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.7% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥25.7bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥25.7bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥1.8bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥13.7bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥13.7bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥162m |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥10.2bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥10.2bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥638m |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥16.0bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥16.0bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥765m |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥49.4bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥49.4bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥16.8bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥24.9bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥24.9bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | segment profit | 2021-01-01 → 2021-06-30 | −¥1.2bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥12.9bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥12.9bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥326m |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥1.1bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥13.4bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥13.4bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥464m |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥40.0bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥40.0bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥12.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 560
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 42532752 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 5264000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1247 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 2726000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0646 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 1682000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0398 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 1283000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0304 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 1192000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0282 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 1082000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0256 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 830000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0197 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 828000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0196 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 796000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0189 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 765000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0181 | |
| Number of shares held | CurrentQuarterInstant | 16452000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.3896 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 303000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 42212600 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 422126 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 17152 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 42532752 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 422126 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 303000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 303000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0071 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 303000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 303000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0071 | |
| Cash and deposits | Prior1YearInstant | 135023000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 139978000000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 59877000000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | － | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | － | JPY |
| Notes and accounts receivable trade and contract assets | CurrentQuarterInstant | 56494000000 | JPY |
| Short term investment securities | Prior1YearInstant | 2012000000 | JPY |
| Short term investment securities | CurrentQuarterInstant | 1559000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 17864000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |